Search

COVID-19 may alter NMOSD and MS risk and appears to be related to genetic susceptibility, a systemic review indicates. Multiple sclerosis (MS) is a common central nervous system (CNS) condition with axonal damage, and its pathogenesis is unclear, though much is known about its risk factors. On the other hand, neuromyelitis optica spectrum disorder (NMOSD) is...

Viral load rebound, symptom rebound common with VV116, nirmatrelvir-ritonavir in mild-to-moderate COVID-19 For patients with mild-to-moderate COVID-19, viral load rebound and symptom rebound can occur after a standard five-day course of treatment with VV116 or nirmatrelvir-ritonavir, according to a study published online March 13 in JAMA Network Open. Zhitao Yang, M.D., from Ruijin Hospital in Shanghai,...

Research suggests that vitiligo patients may experience a decreased risk of hospitalization and death from COVID-19. The potentially protective effects against infection with SARS-CoV-2 may be explained by different mechanisms. Vitiligo has been linked to a lower quality of life and a variety of autoimmune disorders, which may increase the likelihood of poor COVID-19 outcomes....

Message from the National MS Society: We are closely watching the coronavirus (COVID-19) situation and taking action as we all move through this uncharted territory. The most recent guidance from the Centers for Disease Control and Prevention (CDC) about in-person gatherings has a significant impact on all we had planned for the next couple months—from...

In this MD Newsline exclusive interview with obstetrician and gynecologist Dr. Wendy Goodall McDonald, we discuss the perception of vaccination in general and the perception of the COVID-19 vaccine in particular among minority patients. MD Newsline: Can you speak to the question, will minority patients get vaccinated for COVID-19? Dr. Wendy McDonald: “During COVID-19, we’ve...

There is an association between the development/exacerbation of AA and SARS-CoV-2 infection. However, more studies are required to evaluate this association and contribute to improvement in the dermatological and psychological outcomes in patients with COVID-19. COVID-19 is a viral SARS-CoV-2 infection associated with several immune-related dermatological conditions. Alopecia areata (AA) is an autoimmune disease with...

Several COVID-19 vaccines have been developed, but additional effective vaccines are still needed to meet the global demand. A study showed that the fast appearance and spread of SARS-CoV2 variants of concern (VOCs), which have the potential to evade neutralizing antibodies or cell-mediated immunity, can jeopardize vaccine effectiveness (VE). Several pneumonia cases with unclear etiologies...

Sickle cell disease (SCD) is a serious condition that disproportionately affects Black individuals, affecting 1 out of every 365 Black Americans. This hemoglobinopathy puts individuals at risk of developing pulmonary complications. Because of this fact, it is believed that SCD can increase the risk of COVID-19. However, little research has been done to study the...

U.S. immigrants are heavily affected by disasters, including pandemics. This study aimed to better understand how the COVID-19 pandemic has impacted American immigrants and their communities. During the spring of 2020, researchers created eight online focus groups. Participants had to meet specific criteria to participate. In total, 45 immigrants ages 18 and over took part...

Factors linked to structural racism and social determinants of health are associated with an increased risk for COVID-19 in Latino communities, according to a study published online July 23 in the Annals of Epidemiology. Carlos E. Rodriguez-Diaz, Ph.D., from the Milken Institute School of Public Health at George Washington University in Washington, D.C., and colleagues compared...